부산대학교 도서관

Esther Conde, MD, PhD; Susana Hernandez, PhD; Jose Luis Rodriguez Carrillo, MD; Rebeca Martinez, APT; Marta Alonso, APT; Daniel Curto, MD; Beatriz Jimenez, MD; Alejandra Caminoa, MD, PhD; Amparo Benito, MD; Pilar Garrido, MD, PhD; Sergi Clave, PhD; Edurne Arriola, MD, PhD; Isabel Esteban-Rodriguez, MD, PhD; Javier De Castro, MD, PhD; Irene Sansano, MD; Enriqueta Felip, MD, PhD; Federico Rojo, MD, PhD; Manuel Dómine, MD, PhD; Ihab Abdulkader, MD, PhD; Jorge Garcia-Gonzalez, MD; Cristina Teixido, PhD; Noemi Reguart, MD, PhD; Desamparados Compañ, MD, PhD; Amelia Insa, MD; Nuria Mancheño, MD, PhD; Sarai Palanca, MD, PhD; Oscar Juan-Vidal, MD, PhD; Nuria Baixeras, MD; Ernest Nadal, MD, PhD; Maria Cebollero, MD; Antonio Calles, MD; Paloma Martin, MD, PhD; Clara Salas, MD, PhD; Mariano Provencio, MD, PhD; Ignacio Aranda, MD, PhD; Bartomeu Massuti, MD; Laura Lopez-Vilaro, MD; Margarita Majem, MD, PhD; Luis Paz-Ares, MD, PhD; Fernando Lopez-Rios, MD, PhD

JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100653- (2024)

Edurne Arriola, MD, PhD; José Manuel Trigo, MD; Amparo Sánchez-Gastaldo, MD; Alejandro Navarro, MD; Coral Perez, MD; Leonardo Crama, MD; Santiago Ponce-Aix, MD

JTO Clinical and Research Reports, Vol 3, Iss 1, Pp 100266- (2022)

Pedro Rocha, MD; Didac Ramal, MD; Enric Ripoll, MD; Laura Moliner, MD; Alex Corbera, MD; Max Hardy-Werbin, MD, PhD; Mayra Orrillo, MD; Álvaro Taus, MD; Flavio Zuccarino, MD; Joan Gibert; Júlia Perera-Bel; David Casadevall, MD, PhD; Edurne Arriola, MD, PhD

JTO Clinical and Research Reports, Vol 2, Iss 1, Pp 100115- (2021)

Laura Moliner, MD; Jaume Capellades, MD; Álvaro Taus, MD; Edurne Arriola, MD, PhD

JTO Clinical and Research Reports, Vol 1, Iss 3, Pp 100070- (2020)

Güerri, Ignacio Sánchez; Clave, Sergi; Giner-Pichel, Mario; Edurne, Arriola; Sánchez-Font, Albert; Taus, Alvaro; Chalela, Roberto; Bellosillo, Beatriz; Lloveras, Belen

In Journal of the American Society of Cytopathology November-December 2022 11(6):S47-S47

Novello, Silvia ; Rabinovich, Natalie Maimon ; Shih, Jin-Yuan ; Pelizzari, Giacomo ; Stevenson, James ; Majem, Margarita ; Ferreira, Carlos Gil ; Petty, William J. ; Arriola, Edurne ; Castagneris, Nicolas ; De Castro, Javier ; Morbeck, Igor ; Bauman, Jessica ; Toschi, Luca ; Zer, Alona ; Metro, Giulio ; Kalmadi, Sujith ; Martinez, Aitor Azkarate ; Al Husaini, Hamed ; Meloni, Alison R. ; Nduka, Chidozie ; Ardito-Abraham, Christine ; Xia, Caihong ; Awad, Mark M.

In JTO Clinical and Research Reports February 2026

Nassar, Amin H. ; Kim, So Yeon ; Aredo, Jacqueline V. ; Feng, Jamie ; Shepherd, Frances ; Xu, Chao ; Kaldas, David ; Gray, Jhanelle E. ; Dilling, Thomas J. ; Neal, Joel W. ; Wakelee, Heather A. ; Liu, Yufei ; Lin, Steven H. ; Abuali, Tariq ; Amini, Arya ; Nie, Yunan ; Patil, Tejas ; Lobachov, Anastasiya ; Bar, Jair ; Fitzgerald, Bailey ; Fujiwara, Yu ; Marron, Thomas U. ; Thummalapalli, Rohit ; Yu, Helena ; Owen, Dwight H. ; Sharp, John ; Farid, Saira ; Rocha, Pedro ; Arriola, Edurne ; D’Aiello, Angelica ; Cheng, Haiying ; Whitaker, Ryan ; Parikh, Kaushal ; Ashara, Yash ; Chen, Luxi ; Sankar, Kamya ; Harris, Jeremy P. ; Nagasaka, Misako ; Ayanambakkam, Adanma ; Velazquez, Ana I. ; Ragavan, Meera ; Lin, Jessica J. ; Piotrowska, Zofia ; Wilgucki, Molly ; Reuss, Joshua ; Luders, Heike ; Grohe, Christian ; Baena Espinar, Javier ; Feiner, Ella ; Punekar, Salman R. ; Gupta, Shruti ; Leal, Ticiana ; Kwiatkowski, David J. ; Mak, Raymond H. ; Adib, Elio ; Naqash, Abdul Rafeh ; Goldberg, Sarah B.

In Journal of Thoracic Oncology June 2024 19(6):928-940

Conde, Esther ; Hernandez, Susana ; Martinez, Rebeca ; Angulo, Barbara ; De Castro, Javier ; Collazo-Lorduy, Ana ; Jimenez, Beatriz ; Muriel, Alfonso ; Mate, Jose Luis ; Moran, Teresa ; Aranda, Ignacio ; Massuti, Bartomeu ; Rojo, Federico ; Domine, Manuel ; Sansano, Irene ; Garcia, Felip ; Felip, Enriqueta ; Mancheño, Nuria ; Juan, Oscar ; Sanz, Julian ; Gonzalez-Larriba, Jose Luis ; Atienza-Cuevas, Lidia ; Arriola-Arellano, Esperanza ; Abdulkader, Ihab ; Garcia-Gonzalez, Jorge ; Camacho, Carmen ; Rodriguez-Abreu, Delvys ; Teixido, Cristina ; Reguart, Noemi ; Gonzalez-Piñeiro, Ana ; Lazaro-Quintela, Martin ; Lozano, Maria Dolores ; Gurpide, Alfonso ; Gomez-Roman, Javier ; Lopez-Brea, Marta ; Pijuan, Lara ; Salido, Marta ; Arriola, Edurne ; Company, Amparo ; Insa, Amelia ; Esteban-Rodriguez, Isabel ; Saiz, Monica ; Azkona, Eider ; Alvarez, Ramiro ; Artal, Angel ; Plaza, Maria Luz ; Aguiar, David ; Enguita, Ana Belen ; Benito, Amparo ; Paz-Ares, Luis ; Garrido, Pilar ; Lopez-Rios, Fernando

In Journal of Thoracic Oncology December 2019 14(12):2120-2132

Reck, Martin ; Hagiwara, Koichi ; Han, Baohui ; Tjulandin, Sergei ; Grohé, Christian ; Yokoi, Takashi ; Morabito, Alessandro ; Novello, Silvia ; Arriola, Edurne ; Molinier, Olivier ; McCormack, Rose ; Ratcliffe, Marianne ; Normanno, Nicola

In Journal of Thoracic Oncology October 2016 11(10):1682-1689

Arriola, Edurne ; Wheater, Matthew ; Galea, Ian ; Cross, Nadia ; Maishman, Tom ; Hamid, Debbie ; Stanton, Louise ; Cave, Judith ; Geldart, Tom ; Mulatero, Clive ; Potter, Vannessa ; Danson, Sarah ; Woll, Pennella J. ; Griffiths, Richard ; Nolan, Luke ; Ottensmeier, Christian

In Journal of Thoracic Oncology September 2016 11(9):1511-1521

Salido, Marta ; Pijuan, Lara ; Martínez-Avilés, Luz ; Galván, Ana B. ; Cañadas, Israel ; Rovira, Ana ; Zanui, Montserrat ; Martínez, Alejandro ; Longarón, Raquel ; Sole, Francisco ; Serrano, Sergio ; Bellosillo, Beatriz ; Wynes, Murry W. ; Albanell, Joan ; Hirsch, Fred R. ; Arriola, Edurne

In Journal of Thoracic Oncology January 2011 6(1):21-27

Novello, Silvia ; Scagliotti, Giorgio ; de Castro, Gilberto, Jr. ; Kiyik, Murat ; Kowalyszyn, Rubén ; Deppermann, Karl-Matthias ; Arriola, Edurne ; Bosquee, Lionel ; Novosiadly, Ruslan D. ; Nguyen, Tuan S. ; Forest, Amelie ; Tang, Shande ; Kambhampati, Siva Rama Prasad ; Cosaert, Jan ; Reck, Martin

In Journal of Thoracic Oncology February 2017 12(2):383-389

Vidal, Joana ; Clavé, Sergi ; de Muga, Silvia ; González, Iria ; Pijuan, Lara ; Gimeno, Javier ; Remón, Jordi ; Reguart, Noemí ; Viñolas, Nuria ; Gironés, Regina ; Bernet, Laia ; Majem, Margarita ; Bosch-Barrera, Joaquim ; Porta, Rut ; Alonso, Nieves ; Palmero, Ramón ; Taus, Álvaro ; Albanell, Joan ; Espinet, Blanca ; Salido, Marta ; Arriola, Edurne

In Journal of Thoracic Oncology December 2014 9(12):1816-1820

Monzonís, Xavier; Arriola, Edurne

In Journal of Thoracic Oncology November 2019 14(11):e247-e248

Rocha, Pedro ; Hardy-Werbin, Max ; Naranjo, Dolores ; Taus, Álvaro ; Rodrigo, Maite ; Zuccarino, Flavio ; Roth, René ; Wood, Oliver ; Ottensmeier, Christian H. ; Arriola, Edurne

In Journal of Thoracic Oncology October 2018 13(10):e193-e196

Luque, Ana ; Arriola, Edurne; Martínez-Avilés, Luz; Vollmer, Iván

In Journal of Thoracic Oncology June 2014 9(6):e47-e48

Mompradé, Elisabet; Arriola, Edurne ; Martínez-Avilés, Luz

In Journal of Thoracic Oncology April 2013 8(4):e36-e37

Wermke M; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Gambardella V; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Kuboki Y; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Felip E; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Sanmamed MF; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Alese OB; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Sayehli CM; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Arriola E; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Wolf J; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Villaruz LC; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Bertulis J; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Studeny M; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Bouzaggou M; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Fang X; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.; Morgensztern D; Martin Wermke, MD, TU Dresden University of Technology, NCT/UCC Early Clinical Trial Unit, Dresden, Germany; Valentina Gambardella, MD, PhD, Department of Medical Oncology, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain; Yasutoshi Kuboki, MD, PhD, Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Enriqueta Felip, MD, PhD, Department of Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, pain; Miguel F. Sanmamed, MD, PhD, Department of Oncology, Clínica Universidad de Navarra, Pamplona, Spain; Olatunji B. Alese, MD, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; Cyrus M. Sayehli, MD, Interdisciplinary Study Center with ECTU, Medical Clinic and Polyclinic II of the University Hospital, Würzburg, Germany; Edurne Arriola, MD, PhD, Department of Medical Oncology, Hospital del Mar-CIBERONC (Centro de Investigación Biomédica en Red de Oncología), Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain; Jürgen Wolf, MD, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany; Liza C. Villaruz, MD, Division of Hematology/Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA; Julia Bertulis, BSc, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riß, Germany; Matus Studeny, MD, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany; Mohamed Bouzaggou, PhD, Boehringer Ingelheim France S.A.S., Reims, France; Xiaoyan Fang, MD, PhD, Boehringer Ingelheim (China) Investment Co, Ltd, Shanghai, China; and Daniel Morgensztern, MD, Washington University School of Medicine, St Louis, MO.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE